Decitabine+Cladribine+Cytarabine+Granulocyte Colony-stimulating Factor (D-CLAG) for Relapsed or Refractory Acute Myeloid Leukemia (AML)

NAUnknownINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2023

Conditions
Acute Myeloid Leukemia
Interventions
PROCEDURE

D-CLAG

Decitabine+Cladribine+Cytarabine+Granulocyte Colony Stimulating Factor

Trial Locations (1)

310003

RECRUITING

the First Affiliated Hospital,School of Medicine, Zhejiang University, Hangzhou

All Listed Sponsors
collaborator

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

collaborator

Sir Run Run Shaw Hospital

OTHER

collaborator

Zhejiang Provincial People's Hospital

OTHER

collaborator

First People's Hospital of Hangzhou

OTHER

collaborator

Zhejiang Provincial Tongde Hospital

OTHER

collaborator

Jinhua Central Hospital

OTHER

collaborator

Huizhou Municipal Central Hospital

OTHER

collaborator

The Sixth Affiliated Hospital of Wenzhou Medical University

OTHER

collaborator

First Affiliated Hospital of Wenzhou Medical University

OTHER

collaborator

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

INDUSTRY

collaborator

Hanhui Pharmaceutical Co., Ltd

INDUSTRY

lead

Zhejiang University

OTHER